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Application of synthetic vascular implants has con-
siderably improved treatment results in vascular surgery. 
However, implanting artificial bypasses might bring 
about complications of which graft infection seems to 
pose a major threat. The incidence of the infection is 
7% (Herrera et al., 2009) and it is correlated with a high 
mortality rate (up to 75% in the aortic segment) and an 
extremely high risk (up to 70%) of a complete or partial 
loss of the limb. In most cases, the vascular implant gets 
contaminated by microorganisms during an operation. 
A surgeon makes the patient’s vessels accessible by incis-
ing or puncturing the inguinal region. Being naturally 
colonized by numerous microorganisms, this region is 
considered one of the major risk factors for infection 
of vascular implant (Antonios et al., 2006).
Staphylococcus aureus strains and coagulase nega-
tive Staphylococcus spp. are responsible for 70–90% 
infections of vascular bypasses (Bozoglan et al., 2016). 
They produce glycocalyx, which on the one hand, facil-
itates their adhesion to the surface of the prosthesis, 
and on the other hand, it is a component of biofilm 
which serves as protection against phagocytes, anti-
bodies and antibiotics (Bandyk et al., 1991). Of gram-
negative bacteria, Pseudomonas aeruginosa is the most 
common etiological factor contributing to vascular 
implant infections. It causes about 10% of such infec-
tions. Infections caused by P. aeruginosa often result in 
the occurrence of false aneurysms and dissection of the 
vascular wall in the infection site. Esterase and alkaline 
protease, produced by P. aeruginosa, are responsible for 
these processes (Chiesa et al., 2002). 
Gram-positive cocci, including Enterococcus faeca­
lis, have recently become highly contributive factors 
in infections of vascular implants. Several years ago, 
these bacteria were considered relatively harmless 
and were characterized as possessing slight virulence 
traits. Despite being commonly found in human envi-
ronment, they contributed only to a small percentage 
of infections. A characteristic feature of Enterococci is 
their natural resistance to cefalosporins, thus introduc-
tion of cefalosporins to perioperative prophylaxis on 
a great scale led to a great dominance of Enterococci 
in intestinal flora. This, in turn, resulted in an increase 
in the number of dangerous infections induced by 
these bacteria in hospitalized patients. Pathogenicity 
of Enterococci is associated with production of proteins 
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A b s t r a c t
We compared association of Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa and Enterococcus faecalis with 
nine vascular implants after co-culture. Vascular implants were composed of various materials such as warp knitted polyester (with or 
without gelatin and silver ions), expanded polytetrafluoroethylene and biological materials – surface treated porcine pericardial patch and 
Omniflow II. The lowest overall number of associated bacteria was detected for polytetrafluoroethylene implants and porcine pericardial 
patch. The highest overall number of associated bacteria was detected for Omniflow II implant. The major source of variation, i.e. primary 
factor influencing colonization, is the implant type (56.22%), bacterial species is responsible for only 1.81%, and interaction of those two 
factors – 13.09% of variation.
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which facilitate adhesion and colonization of the sur-
face of an artificial prosthesis as well as formation of 
protective biofilm (Bronk and Samet, 2008). 
Unsuccessful treatment of infected vascular implants 
makes scientists implement new strategies in order to 
lessen the risk of infections. Infection-resistant implant-
able material might appear to be that innovation. Such 
material should be characterized with low thrombo-
genicity and immune indifference. 
Implantable materials, currently used in vascular 
surgery, can be divided into three groups: synthetic, bio-
synthetic and biological. Professional literature does not, 
however, contain collective comparative studies on sus-
ceptibility of various implantable materials to infections. 
Vascular prostheses, made of polyethylene tereph-
thalate (Dacron) and polytetrafluoroethylene (PTFE) 
have been commonly applied for more than 50 years. 
PTFE is commonly believed to be less susceptible to 
colonization than Dacron. This observation was ear-
lier confirmed in in vitro studies (Schmitt et al., 1986), 
which revealed that most bacteria are prone to adhere 
to Dacron, rather than to PTFE. Bacterial adhesion to 
synthetic material, which vascular implants are made 
of, is closely associated with its colonization, which 
increases the risk of postoperative infections/compli-
cations in patients. However, clinical studies, compar-
ing complications after implanting Dacron or PTFE, 
did not confirm that one material outdoes the other. 
Patency indices for bypasses manufactured from both 
the synthetic materials, and the number of infection-
induced complications in both the groups were similar 
(Post et al., 2001; Jensen et al., 2007).
Scientists had high hopes that biosynthetic prosthe-
ses would make infection-resistant implantable mate-
rial. One of such prostheses is a composite bioprosthesis, 
Omniflow II. Its complex structure consists of polyester 
mesh (a supportive element and framework for biolo- 
gical component) which is coated with ovine collagen 
(facilitating permeation of the graft wall through the 
recipient’s vessels and tissues). The ability of Omni-
flow II prostheses to easily heal in the recipient’s body 
has been known for more than 20 years (Werkmeister 
et al., 1995). This property makes them an alternative 
for autologous material in the process of creating a vas-
cular bypass (Dünschede et al., 2015) or arteriovenous 
access for dialysis (Palumbo et al., 2009). Application of 
Omniflow II prostheses in treatment of synthetic pros-
thesis infections is an interesting observation. In 2012 
Töpel et al. (2012) presented the first benefits of Omni-
flow II prostheses which replaced infected bypasses, 
located below inguinal ligaments. In 2015 Krasznai et al. 
(2016) presented reconstruction of infected synthe tic 
bypasses with Omniflow II prostheses in the aortoiliac 
segment. Most authors claim that Omniflow II pros-
theses are highly beneficial since they are resistant 
to re-infections and degenerative changes. In a study 
conducted on rat models, Bozoglan et al. (2016) com-
pared PTFE and Omniflow II biosynthetic prostheses 
in terms of their resistance to S. aureus infections and 
the authors arrived at completely different conclusions. 
They confirmed that Omniflow II prosthesis is more 
susceptible to infections than PTFE prosthesis.
For dozens of years scientists have also been con-
ducting clinical studies on application of biological 
prostheses. They include patches, implants and valves 
produced from bovine or porcine pericardium, pre-
pared according to the No-React technology (multi-
stage detoxification process with the use of glutaral-
dehyde). Due to this technology, biological material 
is biocompatible with recipient’s tissues and the bio-
component is protected against calcification. Biological 
material which has been prepared with the application 
of the above technology gets covered with endothe-
lium within 6 weeks. The endothelial coating provides 
a natural barriers against infections. After conducting 
studies for longer than a decade, Musci et al. (2013) 
presented positive findings regarding application of 
biological prostheses in treating infectious endocardi-
tis. Those positive results might encourage for a wider 
use of such prostheses. In a different study, Avsar et al. 
(2013) presented early results of using bovine internal 
mammary arteries, also prepared in the No-React tech-
nology. A number of patients were implanted 33 femo-
ropopliteal bypasses, 100% of which remained patent 
one year following the surgery. The authors did not 
observe infections of the grafts, either. 
The aim of our study was to compare susceptibility 
of selected synthetic and biological implantable materi-
als, applied in vascular surgery, to colonization in vitro 
by S. aureus, S. epidermidis, P. aeruginosa and E. faecalis.
Despite the fact that, in vitro experiments using 
abiotic medical devices and laboratory cultures lack 
the component of host produced proteins and specific 
protein-interactions, co-culture allows comparison of 
colonization using controlled condition by quantifica-
tion of implant related bacteria.
In the study we tested 9 types of implants (num-
bered in the text 1 through 9), all types and their manu-
facturers are listed in Table I. The implants were made 
from various materials such as warp knitted polyester 
(with additional surface covering substances such as 
gelatin and silver ions), expanded polytetrafluoroethy-
lene and two biological implants-surface treated por-
cine pericardial patch and Omniflow II. 
To determine number of bacteria associated with 
implants, we used strains that represent the most com-
mon causes of vascular implant infections i.e. S. aureus 
(ATCC 29213), S. epidermidis (ATCC 14990), P. aeru­
ginosa (ATCC 27853) and E. faecalis (ATCC 29212). 
Overnight cultures of each of the strains were diluted 
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in 75 ml of fresh TSB medium in 300 ml flask and frag-
ments of sterile implants were placed in the diluted cul-
ture. Implants were incubated with bacteria for 24 h at 
37°C with gentle mixing (100 rpm) to assure contact 
of the whole implant surface with the bacterial culture. 
After 24 h bacterial culture was decanted and implants 
were washed five times with 100 ml of sterile buffered 
saline (PBS). After the wash, each implant fragment 
was transferred to 7 ml of sterile PBS in a glass tube and 
bacteria associated with the implant were detached by 
sonication for 5 minutes on ice (Branson Sonifier 250, 
micro tip, output control 6, constant duty cycle). PBS 
with detached bacteria was serially diluted, plated on 
TSA solid medium and colony forming units (CFU) 
from 2–3 dilutions for each experimental variant were 
counted the next day. The experiment was repeated 
independently for at least 3 fragments for each implant/
bacterial species combinations. To calculate the number 
of bacteria per cm2 of the implant, we used the formula 
Outliers from the datasets were removed using 
Grubbs’ test (Grubbs, 1950) and the datasets were com-
pared using 1 or 2 way ANOVA, to analyze one (species 
or prosthesis type) or two factor influence (species and 
prosthesis type). 
We detected high colonization rate of all types of de- 
vices (Fig. 1) with median ranging from  1,94 × 106 CFU/
cm2 (implant no. 3) to almost 100 times higher value 
(CFU per 1 ml) × 7
CFU/cm2=
(implant surface in cm2) × 2
Fig. 1. Number of bacteria recovered from implants after 24 h incubation. 
A. Results obtained individually for each bacterial species for implants 1–9 (description in Table 1 and in text). B combined data for all tested bacterial 
species. Each dot represents single bacterial count, from either separate implant or calculated from single dilution of bacteria. Statistical significance 
of observed differences in colonization was assessed using one way ANOVA with nonparametric Kruskal-Wallis test and Dunns multiple comparison 
post-test, * denotes p < 0,05, ** p < 0,01, ***p < 0,001. Statistically significant differences in colonization were detected for pairs 1 vs 3 (***), 1 vs 4 (***), 
1 vs 5 (***), 1 vs 8 (***), 1 vs 9 (***), 2 vs 3 (***), 2 vs 4 (***), 2 vs 5 (***), 2 vs 8 (**), 2 vs 9 (***), 3 vs 6 (***), 3 vs 7 (***), 3 vs 8 (*), 3 vs 9 (***), 
4 vs 6 (**), 4 vs 7 (***), 4 vs 9 (***), 5 vs 6 (***), 5 vs 7 (***), 5 vs 9 (***), 6 vs 8 (*), 6 vs 9 (***), 7 vs 8 (***), 7 vs 9 (***), 8 vs 9 (***)
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1 DALLON H conventional warp knitted polyester vascular graft TRICOMED SA
2 Gelsoft Plus gelatin impreganted, conventional warp knitted polyester VASCUTEC Ltd. a TERUMO Company
  vascular graft
3 IMPRA expanded polytetrafluoroethylene (ePFTE) BARD Peripheral Vascular, Inc.
4 VIABAHN self-expanding endoluminal endoprosthesis consisting W.L.GORE &ASSOCIATES, Inc.
 ENDOPROSTHESIS of an expanded polytetrafluoroethylene lining
  with an external nitinol support extending
  along its entire length
5 FLUENCY PLUS self-expanding Nitinol Stent encapsulated with expanded BARD Peripheral Vascular, Inc.
  polytetrafluoroethylene
6 Zenith Flex AUI AAA full-thickness woven polyester fabric sewn to WILLIAM COOK EUROPE ApS
 Endovascular Graft self-expanding stainless steel Cook-Z stents with
  braided polyester and monofilament polypropylene suture
7 Silver Graft warp-knitted, double-velour vascular polyester prosthesis, B. Braun Melsungen AG Vascular Systems
  impregnated with modified bovine gelatine (Polygelin)
  and coated with a layer of silver on its surface
8 NO-REACT PATCH porcine pericardial patch BioIntegral Surgical, Inc
9 Omniflow II a composite biosynthetic material comprised of polyester Bio Nova International Pty Ltd
 Vascular Prosthesis mesh incorporated within a cross-linked ovine
  fibrocollagenous tissue matrix
Table I
List of implants used in the study.
No. Implant type Material Manufacturer
Fig. 2. The influence of bacterial species on the implant colonization.
Numerals 1–9 denote implant type (as in Table I and in text), Sa – S. aureus, Se – S. epidermidis, Pa – P. aeruginosa, Ef – E. feacalis. Each gray dot repre-
sents single bacterial count, from either separate implant or calculated from single dilution of bacteria. Statistical significance of observed differences 
in colonization was assessed using one way ANOVA with nonparametric Kruskal-Wallis test and Dunns multiple comparison post-test, * denotes 
p < 0.05, ** p < 0.01, ***p < 0.00.1
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1,56 × 108 CFU/cm2 for Omniflow  II, based on com-
bined data recorded for all tested species (p < 0.0001). 
The lowest overall colonization was detected for 
implants no. 3 (Impra), 5 (Fluency) and 8 (porcine 
patch), regardless of the species (Fig. 1A and B). It 
confirms claims of porcine patch manufacturer that 
No-React® proprietary treatment with glutaraldehyde 
significantly lowers infection rate after implantation. 
Low colonization rate for both PFTE implants is also 
not surprising as lower attachment to hydrophobic sur-
face can be expected. 
The highest overall colonization rate was observed 
for Omniflow II (9) implant (Fig. 1), as shown by Bozo-
glan et al. (2016).
Increased susceptibility of Dacron to colonization 
in vitro was usually caused by its greater porosity than 
that of PTFP. Smoothing the Dacron surface with gela-
tin makes it less susceptible to infections in a mouse 
model (Yasim et al., 2006). For polyester implants, we 
did not observe the influence of the treatment with 
gelatin or gelatin and silver ions on the number of 
implant associated bacteria (1 vs 2, and 1 vs 7, Fig. 1B).
Two way ANOVA analysis of the whole dataset 
revealed that the major source of variation, i.e. pri-
mary factor influencing colonization, is the implant 
type (56,22% of total variation, p < 0.0001) and bacterial 
species is responsible for only 1,81% of total variation 
(p < 0.0001). Interaction of those two factors is a source 
of 13,09% of variation (p < 0.0001).
In a conclusion, a factor that the most influences 
colonization is the type and the material of the implant. 
We show that PFTE (No. 3) is colonized to much 
less extent than Omniflow II. The number of bacteria 
of different species associated with various implants 
varies. For example in our experiment, the best colo-
nizer is S. aureus. Aseptics and a perioperative anti- 
biotic therapy still remain the most common methods 
of combating infections of vascular prostheses (Giaco-
metti et al., 2000).
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